[{"image":"https://icons.biorender.com/w75xh75/5dded30dd8d7a100044a0ea7/a2m-tetramer-active.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5dded30dd8d7a100044a0ea7/a2m-tetramer-active.png"},{"image":"https://icons.biorender.com/w75xh75/5dded30dd8d7a100044a0ea6/a2m-tetramer-active.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5dded30dd8d7a100044a0ea6/a2m-tetramer-active.png"},{"image":"https://icons.biorender.com/w75xh75/5dded30dd8d7a100044a0ea5/a2m-tetramer-active.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5dded30dd8d7a100044a0ea5/a2m-tetramer-active.png"},{"image":"https://icons.biorender.com/w75xh75/5dded30dd8d7a100044a0ea4/a2m-tetramer-active.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5dded30dd8d7a100044a0ea4/a2m-tetramer-active.png"},{"image":"https://icons.biorender.com/w75xh75/5dded30dd8d7a100044a0ea3/a2m-tetramer-active.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5dded30dd8d7a100044a0ea3/a2m-tetramer-active.png"},{"image":"https://icons.biorender.com/w75xh75/5dded30dd8d7a100044a0ea2/a2m-tetramer-active.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5dded30dd8d7a100044a0ea2/a2m-tetramer-active.png"},{"image":"https://icons.biorender.com/w75xh75/5dded30dd8d7a100044a0ea1/a2m-tetramer-active.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5dded30dd8d7a100044a0ea1/a2m-tetramer-active.png"},{"image":"https://icons.biorender.com/w75xh75/5dded30dd8d7a100044a0ea0/a2m-tetramer-active.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5dded30dd8d7a100044a0ea0/a2m-tetramer-active.png"},{"image":"https://icons.biorender.com/w75xh75/5dded30dd8d7a100044a0e9f/a2m-tetramer-active.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5dded30dd8d7a100044a0e9f/a2m-tetramer-active.png"},{"image":"https://icons.biorender.com/w75xh75/5dded30dd8d7a100044a0e9e/a2m-tetramer-active.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5dded30dd8d7a100044a0e9e/a2m-tetramer-active.png"},{"image":"https://icons.biorender.com/w75xh75/5dded30dd8d7a100044a0e9d/a2m-tetramer-active.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5dded30dd8d7a100044a0e9d/a2m-tetramer-active.png"},{"image":"https://icons.biorender.com/w75xh75/5dded30dd8d7a100044a0e9c/a2m-tetramer-active.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5dded30dd8d7a100044a0e9c/a2m-tetramer-active.png"},{"image":"https://icons.biorender.com/w75xh75/5dded30dd8d7a100044a0e9b/a2m-tetramer-active.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5dded30dd8d7a100044a0e9b/a2m-tetramer-active.png"},{"image":"https://icons.biorender.com/w75xh75/5dded30dd8d7a100044a0e9a/a2m-tetramer-active.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5dded30dd8d7a100044a0e9a/a2m-tetramer-active.png"}]